Submitted by roany98@gmail.com on Thu, 05/04/2023 - 11:46
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers (Faculty Presentations)
Ghassan Abou-Alfa, MD, MBA
Professor
Memorial Sloan Kettering Cancer Center
New York, New York
Professor
Memorial Sloan Kettering Cancer Center
New York, New York
Richard S Finn, MD
Professor, Department of Medicine, Division of Hematology/Oncology
David Geffen School of Medicine at UCLA
Director, Signal Transduction and Therapeutics Program
Jonsson Comprehensive Cancer Center at UCLA
Los Angeles, California